Phathom Pharmaceuticals, Inc.·4

Dec 19, 5:50 PM ET

Breedlove Robert Charles 4

4 · Phathom Pharmaceuticals, Inc. · Filed Dec 19, 2025

Insider Transaction Report

Form 4
Period: 2025-12-18
Breedlove Robert Charles
Principal Accounting Officer
Transactions
  • Tax Payment

    Common Stock

    2025-12-18$16.28/sh230$3,74447,844 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    6,945.4
Footnotes (1)
  • [F1]Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4